PGT-Aneuploidy Screening

Ensuring a healthy and successful pregnancy

What is PGT-A

Viafet is a leading provider of Preimplantation Genetic Testing for Aneuploidy (PGT-A). This valuable tool allows us to detect any abnormalities in the 24 chromosomes of embryos generated through IVF. 

Indicators of PGT-A

  • Family balancing

  • Advanced reproductive age to avoid chromosomal abnormalities (>35 years)

  • Repeated IVF failure

  • History of recurrent pregnancy loss

  • History of chromosomal abnormality

  • Male factor infertility

Benefits of PGT-A

By using PGTA, you can select and transfer embryos that are free from aneuploidy, thereby increasing the chances of a successful pregnancy and a healthy child. PGT-A allows for:

  • Gender Determination 
  • Enhanced Implantation and Pregnancy Chances
  • Lower Risk of Miscarriage
  • Efficiency in Achieving Pregnancy
  • Increased Likelihood of a Healthy Child

PGT-A at Viafet

At Viafet, our Genomics Laboratory utilizes a unique and cost-effective in-house developed PGT-A approach using Next Generation Sequencing (NGS)  to allow us to screen embryos and accurately select chromosomally normal ones for transfer during an IVF procedure.


Has successfully screened over 500.000 embryos

Uses the most up-to-date methodology and technology

Has accurate and precise detection (zero error rate)

A fast turn around time (24-36 hours)

Accepts biopsies on Day 3, 4, or 5 for Fresh or Frozen Embryo Transfer day 3,4 or 5

Other Reproductive Genetics Tests

An illustration of a cataract, a clouding of the eye's lens. Important for REPRODUCTIVE GENETICS.

Non-Invasive PGT-A

Pre-Implantation Genetic Testing- Monogenic Disorder (PGT-M)

Preimplantation Genetic Testing For Structural Rearrangement (PGT-SR)